Oldest pages

Showing below up to 50 results in range #1 to #50.

1. Congenital malformations of the face‏‎ (11:50, 4 May 2022)
2. Infectious disorders of the oral cavity‏‎ (11:54, 4 May 2022)
3. Non-infectious inflammatory disorders of the oral cavity‏‎ (11:59, 4 May 2022)
4. Benign tumours of the oral cavity‏‎ (12:02, 4 May 2022)
5. Precancerous and malignant tumours of the oral cavity‏‎ (12:05, 4 May 2022)
6. Odontogenic cysts and tumours‏‎ (12:06, 4 May 2022)
7. 1. Developmental malformations of the face. Inflammatory and tumorous diseases of the oral cavity‏‎ (12:07, 4 May 2022)
8. 2. Pathology of the salivary glands‏‎ (12:29, 4 May 2022)
9. 4. Inflammatory and ulcerative disorders of the stomach‏‎ (12:54, 4 May 2022)
10. 3. Diseases of the oesophagus‏‎ (12:54, 4 May 2022)
11. 5. The benign and malignant tumours of the stomach‏‎ (12:57, 4 May 2022)
12. 6. Malformations of the small intestine. Malabsorption. Tumours of the small intestine‏‎ (13:19, 4 May 2022)
13. 7. Diverticulosis of the colon. Pathology of colonic polyps‏‎ (13:26, 4 May 2022)
14. 8. Crohn disease and ulcerative colitis‏‎ (13:28, 4 May 2022)
15. 9. Colorectal malignancies and their relationship to polypous lesions‏‎ (13:30, 4 May 2022)
16. 10. Diseases of the appendix and the peritoneum‏‎ (13:32, 4 May 2022)
17. 11. Hepatic lesions caused by circulatory disorders. Nonviral inflammatory diseases of the liver. Drug hepatopathies‏‎ (13:35, 4 May 2022)
18. 13. Chronic viral hepatitis (aetiology, types), pathomorphology and differential diagnostics, detection of virus associated antigens and their significance)‏‎ (13:38, 4 May 2022)
19. 14. Cirrhosis and hepatic failure (+ alcoholic and fatty liver disease)‏‎ (14:17, 4 May 2022)
20. 15. Tumours and tumourlike conditions of the liver‏‎ (14:22, 4 May 2022)
21. 16. Cholelithiasis (aetiology and complications) and pathology of the extrahepatic biliary tract‏‎ (14:23, 4 May 2022)
22. 17. Acute and chronic pancreatitis. Tumours of the pancreas‏‎ (14:25, 4 May 2022)
23. 18. Renal failure, uraemia. Congenital malformations and cystic diseases of the kidney‏‎ (14:37, 4 May 2022)
24. 19. Glomerulonephritis. Classification according to clinical symptoms. Histologic alterations in glomerulonephritides.‏‎ (14:39, 4 May 2022)
25. 20. Nephrosis syndrome: minimal change, membranous glomerulonephritis, focal segmental glomerulosclerosis, membranoproliferative glomerulonephritis.‏‎ (14:40, 4 May 2022)
26. 21. Nephritic syndrome (acute poststreptococcal glomerulonephritis). Rapidly progressive glomerulonephritis. Diabetic nephropathy.‏‎ (08:25, 5 May 2022)
27. 22. IgA nephropathy, chronic glomerulonephritis. Glomerular lesions associated with systemic disorders (SLE, Henoch-Schönlein purpura, Wegener’s granulomatosis, amyloidosis)‏‎ (08:27, 5 May 2022)
28. 23. Acute tubular necrosis (ischaemic and toxic). Drug-induced (hypersensitive) interstitial nephritis, analgetic nephropathy, urate nephropathy. Acute and chronic pyelonephritis (pathogenesis, morphology, consequences and clinical course)‏‎ (08:29, 5 May 2022)
29. 24. Benign and malignant nephrosclerosis and diffuse cortical necrosis. Urolithiasis and obstructive uropathy.‏‎ (08:30, 5 May 2022)
30. 28. Indolent B cell lymphomas (FL, CLL, MCL, MZL) (+ introduction to haematological malignancies)‏‎ (08:37, 5 May 2022)
31. 27. Reactive lymph node changes‏‎ (08:38, 5 May 2022)
32. 29. High grade B cell lymphomas (BL, DLBCL). Plasma cell neoplasms‏‎ (08:39, 5 May 2022)
33. 30. Hodgkin lymphoma‏‎ (08:41, 5 May 2022)
34. 31. T and NK cell lymphomas‏‎ (08:43, 5 May 2022)
35. 32. Nonneoplastic bone marrow disorders (anaemia, leukocytosis and leukopenia, thrombocytopenia)‏‎ (08:45, 5 May 2022)
36. 33. AML and MDS‏‎ (08:47, 5 May 2022)
37. 34. Myeloproliferative neoplasms‏‎ (08:48, 5 May 2022)
38. 35. Cerebral edema, hydrocephalus, malformations of the brain‏‎ (08:51, 5 May 2022)
39. 36. Dementias and neurodegenerative disorders‏‎ (08:53, 5 May 2022)
40. 37. Demyelinisation disorders‏‎ (08:54, 5 May 2022)
41. 38. Infectious diseases of the CNS‏‎ (08:56, 5 May 2022)
42. 39. Cerebrovascular diseases, intracranial haemorhages‏‎ (08:57, 5 May 2022)
43. 40. Glial central nervous system tumours‏‎ (08:58, 5 May 2022)
44. 41. Nonglial central nervous system tumors‏‎ (09:00, 5 May 2022)
45. 43. Inflammatory, tumorous diseases as well as disorders associated with hyperplasia of the thyroid gland (+ hyperthyroidism and hypothyroidism)‏‎ (09:04, 5 May 2022)
46. 44. Pathology of the parathyroid glands (hyperplasia, adenoma, causes of hypoparathyreoidism). Multiple endocrine neoplasms‏‎ (09:05, 5 May 2022)
47. 45. Causes and clinical consequences of hyperplasia and atrophy of the suprarenal gland. Cortical tumours of the suprarenal gland (morphology, clinical syndromes) Cortical insufficiency of the suprarenal gland. Tumors of the adrenal medulla.‏‎ (09:06, 5 May 2022)
48. 46. Pathogenesis and frequency of soft tissue tumours. Fibrous tumours and tumourlike lesions. Fibrosarcoma. Fibromatoses. Socalled fibrohistiocytic tumors.‏‎ (09:08, 5 May 2022)
49. 48. Tumours of smooth and striated muscle (leiomyoma, leiomyosarcoma, rhabdomyoma and rhabdomyosarcoma, types)‏‎ (09:10, 5 May 2022)
50. 49. Congenital malformations, inflammations and tumors of the penis‏‎ (09:11, 5 May 2022)